We are live on
!
Find out more
CPIM
Columbia Partners Investment Management Portfolio holdings
AUM
$257M
1-Year Est. Return
8.17%
This Fund
S&P 500
This Quarter
Est. Return
+7.93%
1 Year Est. Return
+8.17%
3 Year Est. Return
+69.66%
5 Year Est. Return
+127.32%
10 Year Est. Return
–
AUM
$2.12B
AUM Growth
–
Cap. Flow
+$2.07B
Cap. Flow
% of AUM
98.01%
Top 10 Holdings %
Top 10 Hldgs %
19.01%
Holding
321
New
321
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Core Laboratories
CLB
|
+$56.9M |
| 2 |
EPR Properties
EPR
|
+$56.1M |
| 3 |
HT
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
|
+$46.4M |
| 4 |
Nu Skin
NUS
|
+$40.1M |
| 5 |
Bread Financial
BFH
|
+$38.9M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 13.62% |
| 2 | Consumer Discretionary | 12.73% |
| 3 | Technology | 12.38% |
| 4 | Healthcare | 9.33% |
| 5 | Consumer Staples | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
GSK
GSK
$101B
| $2.54M | 0.12% |
+40,720
| New | +$2.58M |
|
202
E.W. Scripps
SSP
$314M
| $2.51M | 0.12% |
+181,636
| New | +$2.22M |
|
203
Global Payments
GPN
$23.4B
| $2.48M | 0.12% |
+107,108
| New | +$2.5M |
|
|
AKRX
204
DELISTED
Akorn Inc
AKRX
| $2.45M | 0.12% |
+181,272
| New | +$2.56M |
|
205
Timken Company
TKR
$9.03B
| $2.44M | 0.12% |
+60,680
| New | +$2.4M |
|
206
Liquidity Services
LQDT
$1.35B
| $2.44M | 0.12% |
+70,493
| New | +$2.43M |
|
|
RDS.A
207
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.32M | 0.11% |
+38,911
| New | +$2.41M |
|
208
First Commonwealth Financial
FCF
$2.18B
| $2.31M | 0.11% |
+313,457
| New | +$2.24M |
|
|
CALY
209
Callaway Golf Company
CALY
$2.95B
| $2.29M | 0.11% |
+348,484
| New | +$2.32M |
|
|
LCC
210
DELISTED
US AIRWAYS GROUP INC.
LCC
| $2.26M | 0.11% |
+137,774
| New | +$2.33M |
|
211
Medtronic
MDT
$116B
| $2.2M | 0.1% |
+42,764
| New | +$2.11M |
|
212
Herc Holdings
HRI
$5.63B
| $2.19M | 0.1% |
+29,458
| New | +$2.15M |
|
|
ATW
213
DELISTED
Atwood Oceanics
ATW
| $2.17M | 0.1% |
+41,664
| New | +$2.16M |
|
214
WisdomTree
WT
$3.44B
| $2.11M | 0.1% |
+182,437
| New | +$2.13M |
|
215
3M
MMM
$94.8B
| $2.11M | 0.1% |
+23,049
| New | +$2.09M |
|
216
Zimmer Biomet
ZBH
$18.7B
| $2.04M | 0.1% |
+28,107
| New | +$2.1M |
|
217
Eaton
ETN
$179B
| $1.85M | 0.09% |
+28,136
| New | +$1.77M |
|
218
Amgen
AMGN
$225B
| $1.79M | 0.08% |
+18,202
| New | +$1.89M |
|
219
TotalEnergies
TTE
$194B
| $1.78M | 0.08% |
+23,224,488,636
| New | +$2.32M |
|
220
Odyssey Marine Exploration
OMEX
$49.8M
| $1.75M | 0.08% |
+49,418
| New | +$1.86M |
|
221
Quest Diagnostics
DGX
$26.2B
| $1.74M | 0.08% |
+28,676
| New | +$1.71M |
|
222
BP
BP
$111B
| $1.71M | 0.08% |
+49,958
| New | +$1.74M |
|
223
CVS Health
CVS
$121B
| $1.69M | 0.08% |
+29,619
| New | +$1.72M |
|
224
The Bancorp
TBBK
$2.83B
| $1.67M | 0.08% |
+111,555
| New | +$1.51M |
|
|
BEAT
225
DELISTED
BioTelemetry, Inc.
BEAT
| $1.64M | 0.08% |
+278,562
| New | +$937K |
|
Similar funds
REFI
CHA
VAM
HCG
LA
FIMG
PC
PPC
Columbia Partners Investment Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Columbia Partners Investment Management, which disclosed 321 positions worth $2.12B. Its ten largest holdings account for 19% of the portfolio.
Its largest position is Core Laboratories: 401,357 shares worth $60.9M.
By sector, the portfolio is most concentrated in Industrials at 14% of assets, followed by Consumer Discretionary and Technology.
- Columbia Partners Investment Management's largest Q2 2013 buy was Core Laboratories: 401,357 shares worth $60.9M.
- Columbia Partners Investment Management's ten largest holdings make up 19% of its $2.12B portfolio in Q2 2013.
- Columbia Partners Investment Management disclosed 321 positions in Q2 2013, its first 13F filing on record.
Based on Columbia Partners Investment Management's 13F filing for Q2 2013, filed 12 Aug 2013.